Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Matrix metalloproteinases: a review of their structure and role in systemic sclerosis.

Peng WJ, Yan JW, Wan YN, Wang BX, Tao JH, Yang GJ, Pan HF, Wang J.

J Clin Immunol. 2012 Dec;32(6):1409-14. doi: 10.1007/s10875-012-9735-7. Epub 2012 Jul 6. Review.

PMID:
22767184
2.

Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.

Montagnana M, Volpe A, Lippi G, Caramaschi P, Salvagno GL, Biasi D, Bambara LM, Guidi GC.

Clin Biochem. 2007 Aug;40(12):837-42. Epub 2007 Apr 19.

PMID:
17493602
3.

Matrix remodeling in systemic sclerosis.

Leask A.

Semin Immunopathol. 2015 Sep;37(5):559-63. doi: 10.1007/s00281-015-0508-2. Epub 2015 Jul 4. Review.

PMID:
26141607
4.

Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma).

Johnson RW, Reveille JD, McNearney T, Fischbach M, Friedman AW, Ahn C, Arnett FC, Tan FK.

Genes Immun. 2001 Aug;2(5):273-5.

5.

Biology of metalloproteinases.

Amălinei C, Căruntu ID, Bălan RA.

Rom J Morphol Embryol. 2007;48(4):323-34. Review.

6.

Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients.

Indelicato M, Chiarenza V, Libra M, Malaponte G, Bevelacqua V, Marchini M, McCubrey JA, Stivala F, Scorza R, Mazzarino MC.

J Clin Lab Anal. 2006;20(5):173-6.

PMID:
16960901
7.

Matrix metalloproteinases.

Zitka O, Kukacka J, Krizkova S, Huska D, Adam V, Masarik M, Prusa R, Kizek R.

Curr Med Chem. 2010;17(31):3751-68. Review.

PMID:
20846107
8.

Pathogenesis of scleroderma. Collagen.

Jimenez SA, Hitraya E, Varga J.

Rheum Dis Clin North Am. 1996 Nov;22(4):647-74. Review.

PMID:
8923589
9.

Matrix metalloproteinases in lung diseases.

Ohbayashi H.

Curr Protein Pept Sci. 2002 Aug;3(4):409-21. Review.

PMID:
12370004
11.

Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.

Akhmetshina A, Dees C, Pileckyte M, Szucs G, Spriewald BM, Zwerina J, Distler O, Schett G, Distler JH.

Arthritis Rheum. 2008 Aug;58(8):2553-64. doi: 10.1002/art.23677.

13.

Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis.

Ihn H.

J Dermatol Sci. 2008 Feb;49(2):103-13. Epub 2007 Jul 12. Review.

PMID:
17628443
14.
15.
16.

Matrix metalloproteinases in renal development.

Haas CS, Gleason B, Lin S, Tramonti G, Kanwar YS.

Connect Tissue Res. 2004;45(2):73-85. Review.

PMID:
15763922
17.

Systemic sclerosis: genetics and epigenetics.

Luo Y, Wang Y, Wang Q, Xiao R, Lu Q.

J Autoimmun. 2013 Mar;41:161-7. doi: 10.1016/j.jaut.2013.01.012. Epub 2013 Feb 13. Review.

PMID:
23415078
18.

The genetics of systemic sclerosis: an update.

Romano E, Manetti M, Guiducci S, Ceccarelli C, Allanore Y, Matucci-Cerinic M.

Clin Exp Rheumatol. 2011 Mar-Apr;29(2 Suppl 65):S75-86. Epub 2011 May 13. Review.

PMID:
21586222
19.

Scleroderma.

Gilliam AC.

Curr Dir Autoimmun. 2008;10:258-79. doi: 10.1159/000131502. Review.

PMID:
18460891
20.

Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.

Kerkelä E, Saarialho-Kere U.

Exp Dermatol. 2003 Apr;12(2):109-25. Review.

PMID:
12702139
Items per page

Supplemental Content

Write to the Help Desk